ScholarLens Back to search
1999•CHEST JournalRequires access

Pharmacoeconomic Evaluation of a Combination of Ipratropium Plus Albuterol Compared With Ipratropium Alone and Albuterol Alone in COPD

Mitchell Friedman, Charles W. Serby, Shailendra Menjoge, J. Douglas Wilson, Daniel E. Hilleman, Theodore J. Witek

Open publisher page 176 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 176 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Ipratropium, Ipratropium bromide, Medicine, Bronchodilator, Anesthesia, COPD, Exacerbation, Asthma

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
Pharmacoeconomic Evaluation of a Combination of Ipratropium Plus Albuterol Compared With Ipratropium Alone and Albuterol Alone in COPD — Research Paper | ScholarLens